European Journal of Pharmacology 1989-02-28

Biphasic effect of D-2 agonist quinpirole on locomotion and movements.

D Eilam, H Szechtman

文献索引：Eur. J. Pharmacol. 161 , 151-157, (1989)

全文：HTML全文

摘要

The effects of the D-2 agonist quinpirole on forward progression, and on vertical and lateral movements, were measured for 2 h in rats injected with either saline, 0.03, 0.125, 0.5 or 8 mg/kg of the drug. Results showed that the drug had a biphasic effect: the lowest dose decreased and the high doses increased the amount of locomotion and of movement. The decrease in activity produced by the low dose had its onset within minutes after administration of the drug; persistent and marked hyperactivity was observed from about 60-80 min after injection of 0.5-8 mg/kg of quinpirole. Moreover, in animals injected with intermediate doses, the excitation was preceded by a brief period of reduced locomotion. It is suggested that the biphasic effect may reflect two independent actions of the drug, possibly on activity in the nucleus accumbens.

相关化合物

  • (±)-盐酸喹吡罗

相关文献：

Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae.

2011-04-06

[J. Neurosci. 31 , 5512-25, (2011)]

A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.

2015-04-01

[Hum. Mol. Genet. 24(7) , 1929-44, (2015)]

Compounds selective for dopamine receptor subtypes. Kebabian, et al.

[Drug Discov. Today 2 , 333-340, (1997)]

Infusion of quinpirole and muscimol into the ventral tegmental area inhibits fear-potentiated startle: implications for the role of dopamine in fear expression.

1997-01-23

[Brain Res. 746 , 231-238, (1997)]

K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.

1995-08-01

[Pharmacol. Biochem. Behav. 51 , 843-848, (1995)]

更多文献...